Trace Biosciences, Inc., a clinical-stage biotechnology company developing nerve-targeted imaging agents, today announced that the U.S. Food and Drug Administration (FDA) has approved its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results